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Abstract To investigate the molecular events controlling
malignant transformation of human pleural cells, we compared
constitutive gene expression of mesothelioma cells to that of
pleural cells. Using cDNA microarray and high-density filter
array, we assessed expression levels of s 6500 genes. Most of
the highly expressed transcripts were common to both cell lines
and included genes associated with stress response and DNA
repair, outcomes consistent with the radio- and chemo-resistance
of mesothelioma. Interestingly, of the fewer than 300 genes
that differed between cell lines, most functioned in (i) macro-
molecule stability, (ii) cell adhesion and recognition, (iii) cell
migration (invasiveness), and (iv) extended cell division. Expres-
sion levels of several of these genes were confirmed by RT-PCR
and could be useful as diagnostic markers of human meso-
thelioma. ß 2000 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Although the use of asbestos ¢bers has been banned in
most industrialized countries, ¢bers are still a major environ-
mental and occupational health concern. Asbestos has been
identi¢ed as a known human mutagen and carcinogen [1,2],
producing several thousands of cancers each year. In France
alone, asbestos is responsible for approximately 2000 new
cases of bronchogenic carcinomas and mesotheliomas [3].
Mesothelioma is almost unique to asbestos exposure, yet the
molecular mechanism controlling the transformation of pleu-
ral cells is largely unknown. To better understand the malig-
nant conversion of mesothelial cells, we compared the expres-
sion of 6649 mRNAs in a control mesothelial cell line (Met-
5A) to that of a mesothelioma cell line (MSTO-211H) using a
cDNA microarray. These results were compared to 588 se-
lected genes by di¡erential display using high-density ¢lters.
In this paper we found that genes with a high level of con-
stitutive expression that are shared in both cell lines include
genes that may be important in the resistance of these partic-
ular cancer cells to radiotherapy and chemotherapy. In addi-
tion, our ¢ndings from the hierarchy clustering analyses indi-
cated that only a few speci¢c subdivisions di¡er between
mesothelioma and mesothelial cell lines. Common features
about these subdivisions include their roles in macromolecule
stability and metabolism, cell adhesion and molecular recog-
nition, and cell growth and migration (invasion). Each of
these functions could relate to the transformation processes
of mesothelioma.
2. Materials and methods
2.1. Cell lines and mRNA puri¢cation
Two cell lines used in this study, Met-5A (CRL-9444) and MSTO-
211H (CRL-2081, American Type Culture Collection (ATCC), Ma-
nassas, VA, USA), were grown respectively in M199 and RPMI 1640
supplemented with fetal calf serum (10%) according to the instructions
of ATCC and as described previously [4]. When cells reached con£u-
ence, the medium was replaced and 18 h later, total RNA was har-
vested using Trizol1 (Gibco BRL, Grand Island, NY, USA). Poly-
adenylated mRNAs were isolated with Oligotex1 (Qiagen S.A.,
Courtaboeuf, France) and were £uorescently labeled or radiolabeled
for microarray or high-density ¢lter hybridization, respectively.
2.2. Microarrays
Target cDNA was generated from 1 Wg polyadenylated mRNA that
was reverse transcribed to produce cDNA and labeled either with Cy3
(MSTO-211H) or Cy5 (Met-5A) dUTP [5]. The average intensity of
the Cy3 £uorescence divided by the average intensity of the Cy5 £uo-
rescence equaled 0.97 (balance coe⁄cient), indicating similar labeling
e⁄ciency for each set of target cDNAs. Target cDNA was hybridized
on Incyte Pharmaceuticals1 arrays containing 6969 probes with se-
quences complementary to 3962 human genes and 3007 human ex-
pressed sequence tags (ESTs) (Unigem V1, Genome Systems Inc., St
Louis, MO, USA). Following the hybridization and washing, the rel-
ative expression level of both cDNA populations was measured and
compared by making the Cy3/Cy5 £uorescence ratio for each target
cDNA satisfy the inclusion criteria. Inclusion criteria were derived
from an image recognition algorithm for each cDNA in the analysis
and included a £uorescent signal from the cDNA exceeding a signal to
background ratio of 2.5 and the cDNA covering its grid location on
the microarray for s 40%. In this study, genes were considered di¡er-
entially expressed (DE) if the change was s 2.0-fold. The cDNAs
corresponding to genes of known function were sorted by enzyme,
function or pathway cluster analysis using a Gemtools software
(v2.4.2, Incyte Pharmaceuticals, Freemont, CA, USA). The results
from this study can be downloaded (0.7 Mb ¢le) at website: http//
www.inrs.fr/actualite¤s/amiante/GeneMesoen.htm.
2.3. High-density ¢lter arrays
Oligotex1 puri¢ed mRNAs (1 Wg) of both cell populations were
labeled with [32P]KdATP using speci¢c primers and MMLV polymer-
ase (Atlas1 Cancer Human array, Clontech). The target mRNAs (106
Cerenkov cpm) were hybridized overnight (68‡C) on separate ¢lter
arrays, washed (stringent, 68‡C), and the L-radioactivity of each
cDNA was counted with a PhosphorImager BAS20001 (Fuji, Tokyo,
Japan) following a 12 h exposure period. Results were expressed as
the percent of total labeled cDNA (relative abundance). The ratio of
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relative abundance of both cell populations corresponded to the DE
of a given gene. The mean of at least three independent tests was
calculated for each gene of interest.
2.4. Con¢rmatory RT-PCR
cDNAs of both cell lines were ampli¢ed in the presence of SYBR-
Green1 (Master SYBR Green I1) in a Lightcycler1 (Roche Diag-
nostics, Mannheim, Germany). For each cDNA, the set of primers
was chosen according to the clone sequence (Genome Systems Inc.).
The MgCl2 and the cycling parameters were optimized according the
Lightcycler (v3, 1999, Roche). The copy ratio of each analyzed cDNA
was determined as the mean of three experiments.
3. Results and discussion
3.1. Microarrays
Of the 6969 genes analyzed by microarray, 6649 (95.4%)
satis¢ed the inclusion criteria. In mesothelioma cells, the sig-
nal intensity spanned over 10^104 £uorescent units from 65
(epithelial V-like antigen, AI819274) to 36 509 (ferritin, light
polypeptide, AI608953) (Fig. 1). In mesothelial cells, the £uo-
rescence signal had a similar range and varied from 56 (EST
weakly similar to AA523426) to 27 694 (EST, Incyte number
3097582). These ¢ndings re£ect nearly equivalent labeling ef-
¢ciencies. The range of DE varied from +32.2 (plasminogen
activator inhibitor-2, PAI-2, Y00630) to 327.1 (EGF-contain-
ing ¢bulin-like extracellular matrix protein 1, U03877). Re-
spectively 0.1 and 0.3% of genes displayed a DE ranging
from 339 to 35 and from +5 to +39.
Initial analysis of microarrays revealed that most genes
(6356 or 95.6%) were not di¡erent in the mesothelioma cells
as compared to the non-transformed mesothelial cells. How-
ever, 209 (3.1%) genes were increased (s 2 fold) and 84 (1.3%)
were decreased (6 2-fold) in mesothelioma cells. Among these
sequences in mesothelioma cells, 268 encoded known genes
and 25 encoded ESTs with no homology to known genes.
Inasmuch as we screened the expression of approximately
1/10 of the human genome, this ¢nding suggests that at
least 2500 known genes and 250 ESTs could be implicated
in cancer transformation of mesothelial cells. Substantial ef-
forts will be needed to elucidate these genes and their func-
tions.
The distribution of the £uorescence signals of both cDNA
populations was bimodal (Table 1). About 3000 cDNAs had
£uorescence levels ranged from 49 to 499 units corresponding
to low-level expression whereas 2000 cDNAs ranged from
1000 to 4999 units corresponding to moderately expressed
genes. Interestingly, 20 genes had higher expression levels
Fig. 1. Scatter plot of the DE in both cell lines. Lines correspond to the di¡erent DE levels. Each dot corresponds to a gene. The axes repre-
sent the £uorescence levels.
Table 1
Distribution of relative expression levels in both cell lines
Cell line 50 000^10 000 9999^5000 4999^1000 999^500 499^49
Mesothelioma 31 (0.5) 189 (2.8) 2094 (31.5) 1467 (22.1) 2868 (43.1)
Mesothelial 61 (0.9) 178 (2.7) 1965 (29.5) 1494 (22.5) 2951 (44.4)
Percentage of analyzed genes in parentheses.
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with a £uorescence level greater than 5000 units in mesothe-
lioma cells. This compared to only six genes with high-level
expression in mesothelial cells. Note also that about twice as
many genes had a very high expression level (s 10 000 units)
in mesothelial cells as compared to mesothelioma cells (Table
1).
The high similarity in gene expression (s 95%) between
mesothelioma and non-transformed mesothelial cells is strik-
ing and suggests that only an additional 5% (or less) of the
genome is activated during malignant transformation. This is
remarkable since cell division and growth dysregulation is
likely to require augmentation of numerous cellular pathways.
Categorizing genes by related function (hierarchical gene
clustering) allowed assessment of the pathophysiological sig-
ni¢cance of di¡erences in gene expression between the two cell
lines. The ratios of the genes upregulated in mesothelioma
compared to those in mesothelial cells were 2.8, 2.4, and 1.9
for the enzyme, pathway, and function clusters, respectively.
Further subdivision of these gene clusters is shown in Tables 2
and 3. For enzyme cluster, 375 hydrolases, 372 transferases,
52 ligases, 50 isomerases and 49 lyases were screened. In
mesothelioma cells, the ligase subdivision had six genes that
increased as compared to only one gene in mesothelial cells.
In the function cluster, the two subdivisions with the greatest
di¡erences involved genes important in ‘protein modi¢cation
and maintenance’ and ‘adhesion and molecular recognition’
(Table 2). The pathway cluster had the greatest di¡erences in
the ‘transmembrane tra⁄cking’, ‘lipid metabolism’, and ‘cell
division’ subdivisions with ratios of the genes upregulated in
mesothelioma of 6.0, 5.0, and 4.0, respectively, as compared
to 2.4 (the average increase) for mesothelial cells (Table 3). In
addition, the subdivision ‘amino acid metabolism’ contained
four genes that were upregulated in mesothelioma cells that
were unchanged in mesothelial cells.
3.2. High-density ¢lter arrays
The largest changes in up- and downregulated genes in
mesothelioma cells (mean result of three high-density ¢lter
arrays) are shown in Table 4. This analysis included several
sequences contained on cDNA microarray results, but in gen-
eral, most sequences were not included on the microarray.
Thus, direct comparison of the results from the two methods
Table 2
Genes sorted by function clusters
Function cluster Similar
expression
Increased in
mesothelioma cells
Increased in
mesothelial cells
Ratio mesothelioma/
mesothelial
Total screened
genes
Signal transduction and
regulation
1173 25 9 2.7 1207
Membrane transport 164 2 2 1.0 168
Protein modi¢cation and
maintenance
197 20 5 4.0 222
Nucleic acid synthesis and
modi¢cation
118 6 3 2.0 127
Adhesion and molecular
recognition
143 5 0 ^ 148
Electron transfer 69 4 2 2.0 75
Structural and localized
proteins
2037 55 39 1.4 2131
Extracellular membrane 66 2 4 0.5 72
Cytoskeleton 161 3 4 0.7 168
Total 3901 117 63 1.9 4078
Table 3
Genes sorted by pathway clusters
Cluster Similar
expression
Increased in
mesothelioma cells
Increased in
mesothelial cells
Ratio mesothelioma/
mesotheliala
Total screened
genes
Metabolism 1542 73 26 2.8 1641
DNA repair 29 1 0 ^ 30
RNA metabolism 517 14 9 1.5 540
Transcription initiation 401 7 6 1.2 414
Lipid metabolism 147 5 1 5.0 153
Carbohydrate metabolism 98 3 4 0.7 105
Amino acid metabolism 38 4 0 ^ 42
Energy metabolism 75 3 1 3.0 79
Antioxidant defence 11 1 0 ^ 12
Xenobiotic metabolism 39 2 4 0.5 45
Hormone metabolism 24 2 1 2.0 27
Growth and development 650 19 10 1.9 679
Cell division 128 8 2 4.0 138
Proliferation and di¡erentiation 446 12 8 1.5 466
Kinesis 222 6 2 3.0 230
Transmembrane tra⁄cking 162 6 1 6.0 169
Environmental response 111 9 5 1.8 125
In£ammatory response 70 2 2 1.0 74
Total 2595 109 45 2.4 2749
aValues correspond to the ratio of the number of genes overexpressed in mesothelioma to those overexpressed in mesothelial cells.
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is di⁄cult. Nonetheless, several of the genes measured by
either method had comparable changes. For example, the ex-
pression level of PAI-2 was increased 14.4 times in mesothe-
lioma cells in the high-density ¢lter array (Table 4) and 32.2
times in the microarray. The ¢bronectin 1 gene that increased
in mesothelial cells had a DE of 332.4 using the high-density
¢lter array (Table 4) and 321.1 using microarrays. The level
of cytokeratin 8 (AI929696), a proposed marker of mesothe-
lial and mesothelioma cells [6], was similar in both cDNA
populations (high-density ¢lter array: +1.1, microarray:
31.4) though its expression level was high (12 356 in meso-
thelial cells).
3.3. Con¢rmatory RT-PCR
The expression levels of selected genes were con¢rmed by
quantitative RT-PCR using cDNA neosynthesis quantitation
by SYBRGreen1 incorporation on a Lightcycler1 £uorime-
ter (Roche Diagnostics). In general, several of the fold
changes in high-level expression measured by microarray
were similar to, although often somewhat less than, that mea-
sured by quantitative PCR. For example, in mesothelioma
cells, the PAI-2 (Y00630) gene increased 33- and 90-fold using
cDNA microarray and quantitative RT-PCR, respectively.
Likewise, the iodothyronine deiodinase type II gene
(U53506) displayed a 19.2-fold increase using cDNA micro-
array compared to a 40.0-fold increase using quantitative RT-
PCR. At intermediate levels of expression, the results with
each method were more comparable. For example, the se-
quence encoding the pentaxin-related gene increased in meso-
thelioma cells by 7.5-fold when analyzed with cDNA micro-
array and 7.0-fold with RT-PCR. Similarly, several
downregulated genes like ¢bronectin 1 showed concordant
results in both techniques. Genes with high DE con¢rmed
by RT-PCR are good candidates for further validation studies
as new mesothelioma markers.
3.4. Macromolecule stability and metabolism
Changes in macromolecular stability and metabolism were
re£ected by altered expression of the genes involved in protein
metabolism and tra⁄cking, nucleotide interactions, and lipid
metabolism.
Protein metabolism was increased in mesothelioma cells as
shown by the increased expression of four aminoacyl-tRNA
synthetases (lysyl-, isoleucyl-, threonyl-, and arginyl-tRNA
synthetases) the DE of which ranged from +3.7 to +2.1. In
addition, proteins appeared more protected from hydrolysis as
the DEs of the serine protease 11 (D87258) and cathepsin H
(X16832) were respectively 33.8 and 34.0. Moreover, the
correct folding and the macromolecular assembly of proteins
were promoted through a variety of chaperonins. In our study
the 60 kDa (M34664) and 90 kDa (M16600) heat shock pro-
teins, CCT6A chaperonin containing TCP1 (L27706) and
phosphoprotein 1 induced by stress (M86752) were overex-
pressed as their DEs varied from +2.9 to +4.7. Mesothelioma
cells also display improved protein sorting and addressing
properties. Four genes involved in protein import and ad-
dressing were overexpressed: karyopherin L-2 (U72069), pre-
protein translocase (X97544) and 72 kDa signal recognition
particle (AF069765) which participate in respectively nuclear,
mitochondrial and endoplasmic reticulum transport, and tar-
getting of protein. In addition, transmembrane tra⁄cking is
facilitated through annexin A1 (X05908), a protein important
for membrane fusion and exocytosis.
Similarly, proteins related to nucleotide interactions include
genes products related to stabilization of mRNA and DNA.
Degradation of mRNA, for example, may be less pronounced
in mesothelioma cells as indicated by altered expression of
genes encoding the ribonuclease L inhibitor (X76388, DE
+4.8) and ribonuclease 4 (D37931, DE 33.6). In addition,
the nibrin encoding gene (AF049895; DE +2.3), in association
with Mre11 and Rad50, plays a role in double strand repair
and telomere maintenance. Two components of the cyclin
activating kinase, namely cyclin H (AA451817, DE +2.3)
and CDK7 (X77743, DE +2.8), implicated in DNA transcrip-
tion and repair are increased in mesothelioma cells. Also over-
expressed in malignant cells, GADD45A (AI634658, high-
density ¢lter array DE +2.3) stimulates DNA excision and
repair before the entry into S phase. In addition its protein
product binds with proliferating cell nuclear antigen (PCNA;
M15796, high-density ¢lter array DE +3.4) (Table 4).
Lipid metabolism was also a¡ected as FABP5 (AA972250),
ATP citrate lyase (X64330) and 3-oxoacid-CoA transferases
(U62961) were overexpressed. These genes play a central role
in de novo lipid synthesis and FABP5 is involved in keratin-
ocyte di¡erentiation [7]. Type II iodothyronine deiodinase
(U53506) was 19.2 times more expressed in MSTO-211A cells
Table 4
Levels of common expressed genes in MSTO-211 and Met-5A cells analyzed with high-density ¢lter hybridization
Ratio
Genes upregulated in MSTO-211 cells
Rho8 protein (X95282) 16.5
Plasminogen activator inhibitor-2 (M18082) 14.4
c-Myc binding protein (D98667) 10.0
Nucleoside diphosphate kinase NM23 (Y07604) 5.6
Superoxide dismutase 1 (Cu/Zn) (K00065) 3.8
CD59 (M34671) 3.6
PCNA (cyclin) (M15796) 3.4
Integrin K3 (M59911) 2.4
Genes with similar expression levels
Keratin, type ii cytoskeletal 8 (AI929696) 1.1
Proto-oncogene RhoA multidrug resistance protein (L25080) 31.4
Genes upregulated in Met5A cells
Macrophage inhibition factor (M25639) 32.3
Basigin (L20471) 320.5
Fibronectin (X02761) 332.4
The ratio was calculated as the mean of three independent experiments.
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than Met-5A cells. The enzyme encoded by this gene converts
thyroxine to active T3 thyroid hormone. This process is crit-
ical in thyroid hormone economy and could increase metab-
olism in target cells. Thus, the macromolecule and the lipid
metabolisms were changed in cancer cells compared to their
non-transformed counterparts.
3.5. Adhesion and cell recognition
Integrins are known to play a role in extracellular matrix
adhesion. Many integrin genes were upregulated in mesothe-
lioma cells like integrin K3 (M59911), K4 (X16983), K6
(X53586) and L-like 1 (AF072752): the DEs were +2.4,
+6.4, +7.5, and +6.2, respectively. The K6-L1 and K4-L1 het-
erodimers are receptors of laminins and V-CAM proteins.
Indeed the laminin K4 and Q1 genes were overexpressed (DE
+3.0 and +3.1, respectively) in mesothelioma cells also giving
them increased e⁄ciency in angiogenesis. Previously, seven
human malignant mesothelioma cell lines have been found
to overexpress the K3-L1 integrin heterodimer as measured
by immuno£uorescence and FACS [8]. In agreement with an-
other previous study, we found two genes CD59 (M34671)
and MIF (M25639), of which the DEs were respectively
+3.6 and 32.3 using the high-density ¢lter array (Table 4).
These genes were shown to act by lowering the local in£am-
mation and immune response. Indeed CD59 is a potent inhib-
itor of the complement attack complex action and protects
malignant cells from C-mediated lysis. MIF, downregulated
in mesothelioma cells, encodes a factor inhibiting macrophage
migration and maintaining them activated at in£ammatory
loci.
3.6. Invasion
Human mesothelioma is characterized by local invasion,
recurrence following surgery and a weak ability for metastasis
[9]. The inhibition of ¢bronectin 1 (X02761) expression in
mesothelioma cells, compared to mesothelial cells (DE
321.1), may partially explain the local proliferation of the
cells. For example, Bourdoulos et al. [10] previously reported
¢bronectin has anti-migration and anti-proliferation proper-
ties, demonstrated by an inhibition of cdc 42. Using the same
mesothelial (Met-5A) cell line, Kinnula et al. [11] found that
¢bronectin synthesis could be induced by transforming growth
factor L, but not amosite, a variety of asbestos. Moreover,
¢bronectin concentrations were low or undetectable in ¢ve
of six mesothelioma cell lines. In our study with the micro-
array, the £uorescence level of ¢bronectin cDNA was 196 (a
very low level) and 4265 in mesothelioma and mesothelial
cells, respectively. The localization of mesothelioma may
also be related to secretion of V-CAM interacting integrins
(discussed above) and BYSL (L36720; DE +2.4) which is
involved in initial attachment of the blastocysts to the uterine
epithelial cells.
In contrast to other lung tumors, mesothelioma rarely in-
duces metastasis. PAI-2 (M31551) was markedly expressed in
mesothelioma cells (DE +33.2). Interestingly, PAI-2 expres-
sion has been associated with the absence of nodal invasion
of non-small cell lung carcinomas [12]. In addition, thrombo-
spondin 2 (L12350) was overexpressed in mesothelioma cells
(DE +4.2), and when overexpressed can have an inhibitory
role in vascularization and progression in non-small cell lung
cancers [13]. The isoform of this gene, thrombospondin 1,
highly expressed in 74 of 78 malignant mesotheliomas (as-
sessed by RT-PCR), is signi¢cantly lower in tumors with as
compared to without lymph node metastasis [14].
Another gene, basigin (L20471, high-density ¢lter DE
320.5), that decreased in mesothelioma cells encodes a glyco-
protein that alters matrix metalloproteinase expression. Ma-
trix metalloproteinases are important during tumor invasion
and correlated with the metastasis phenotype of bronchopul-
monary carcinomas [15]. In addition, we found tissue inhib-
itor of matrix metalloproteinase-3 (TIMP-3, D45917) was up-
regulated in mesothelioma cells (DE +3.4). The combined
diminution of basigin and the presence of TIMP-3 gene prod-
ucts could act synergistically to delimit the metastatic poten-
tial of these cells.
Lei et al. [16] previously demonstrated that certain attri-
butes of bronchopulmonary tumors (malignancy grade and
the metastasis potential) were inversely correlated with nu-
cleoside diphosphate kinase NM23-H4 (Y07604) expression
levels. In agreement, our high-density ¢lter array results
showed an overexpression of this gene (DE +5.6, Table 4).
Taken together, these data highlight our understanding of the
low metastatic potential of mesotheliomas.
3.7. Genes involved in cell cycle and cell growth
Various genes implicated in cell cycle control were overex-
pressed (DE varying from +2.4 to +3.8) in mesothelioma as
compared to mesothelial cells even though both mRNA pop-
ulations were extracted from con£uent cells. These included
G1 to S phase transition 1 gene (U95742), proliferation-asso-
ciated 2G4 (AF104670) encoding gene involved in metaphase,
cell division cycle 27 (S78234) involved in anaphase entry,
cyclin H (AA451817) and cdk-7 (X77743) involved in various
phases of the cell cycle. Other gene products involved in cell
proliferation were also upregulated in mesothelioma cells in-
cluded the proto-oncogenes Ki-ras (AI740449; cDNA micro-
array DE +2.6) and c-myc (K01904; cDNA microarray 10 024
£uorescence level), and a regulatory protein, c-myc binding
protein (D98667; high-density ¢lter DE +10.0). Both proto-
oncogenes are cell markers of the MSTO-211H cell line
(ATCC technical data sheet) and c-myc was previously shown
to be expressed in mesothelioma by immunoreactivity [17^19].
The mitogen-stimulated ornithine decarboxylase-1 (M81740),
which increases in rat mesothelial cells following exposure to
crocidolite ¢bers [20], also was overexpressed in mesothelioma
cells (cDNA microarray DE +8.4). Finally, two sequences for
the basic ¢broblast growth factor (bFGF; J04513) and the
serum-inducible kinase (AF059617) were increased in meso-
thelioma cells, and bFGF previously has been found in 92%
of human mesotheliomas and correlates with tumor aggres-
siveness [21].
3.8. Xenobiotic resistance and oxidative stress response genes
Human malignant mesothelioma has long been known to
be extremely resistant to chemotherapy but the cellular and
subcellular mechanisms remain largely unknown. A battery of
genes involved in drug resistance expressed in both cell lines
may help to explain why mesothelial cells are intrinsically re-
sistant. These genes included four glutathione S-transferase
genes including the a2 isoform (L38503), nine cytochrome
P450 genes including the 2B subfamily (M29874), three drug
transporter molecules including tetracycline transporter-like
protein (L11669) and P glycoprotein 3/multiple drug resis-
tance 3 (X06181). Xenobiotic intermediate metabolism and
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detoxication genes included epoxide hydrolase 2, cytoplasmic
(AI301066) and deoxyguanosine kinase (AA625191). These
genes were moderately or highly expressed (£uorescence
s 500 units) in both cell lines. In addition, two genes involved
in detoxi¢cation of the cytostatic drugs ^ 5-£uorouracil
through dihydropyrimidine dehydrogenase (U20938) and
bleomycin through bleomycin hydrolase (X92106) ^ were
overexpressed (cDNA microarray DE +2.1 and +2.9, respec-
tively).
In addition, several genes important in the response to oxi-
dative stress were increased in mesothelioma cells. These in-
cluded Q-glutamylcysteine synthetase (AL033397, cDNA mi-
croarray DE +2.4, previously found to be overexpressed in
¢ve human mesothelioma tumors by Ogretment et al. [22]),
proliferation-associated gene A (L19184; cDNA microarray
DE +3.3), superoxide dismutase Cu/Zn (K00065; high-density
¢lter DE +3.8), annexin I (X05908; cDNA microarray DE
+9.4, previously found to downregulate phospholipase A2),
and thioredoxin (AI302890; cDNA microarray DE +2.5). In-
terestingly, the latter two genes were implicated by Sinha et al.
[23] in chemoresistance of human stomach cancer cells.
4. Conclusion
We found that simultaneous analyses of thousands of genes
revealed a complex phenotype in mesothelioma that was as-
sociated with changes in several major pathways. Examina-
tion of gene expression that is shared between mesothelial and
mesothelioma cells revealed a battery of proteins allowing
metabolization and detoxication of chemicals and increased
DNA repair e⁄ciency. Regulation of these pathways could
confer functions related to the well-known chemo- and radio-
resistance properties of mesothelioma. Examination of gene
expression that di¡ers between mesothelial and mesothelioma
cells revealed several pathways that may be important in cell
transformation. In addition to the traits of cancer cells re-
cently described by Weinberg and Hanahan [24], namely
self-su⁄ciency in growth signal, tissue invasion, sustained an-
giogenesis and limitless replicative potential, we found altered
regulation of several genes that control other attributes that
distinguished mesothelioma cells from mesothelial cells. Gene
expression linked to cell transformation appear to be related
to (i) increased macromolecule stability, (ii) changes in cell
adhesion and recognition, (iii) limited invasion properties,
(iv) continuous cell division even at high cell density, (v) in-
creased anabolism, and (vi) increased protein transmembrane
transport. These properties may cooperate to explain the
pathogenesis of mesothelial cell transformation to mesothelio-
ma. Further studies comparing the gene expression patterns of
both cultured cells to other cell lines, especially to cancer cells
[25], could be useful. Such studies should foster the research
of molecular markers (as many have suggested) allowing to
better assess the phenotype of malignant mesothelioma. These
strategies could improve the accuracy of its diagnosis, prog-
nosis and therapy including by gene modulation.
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